Welcome to a
New Era of
Alzheimer’s Detection
At Advance Tests, we believe in breaking down barriers to life-saving diagnostics. That’s why we’re thrilled to introduce the LucentAD Complete™ test to the UK—a cutting-edge, multi-marker blood test that redefines Alzheimer’s disease diagnostics. Available exclusively through Advance Tests, LucentAD Complete empowers patients and healthcare providers with fast, accurate, and non-invasive Alzheimer’s risk assessments.
Greater Access to Early Detection
LucentAD Complete is a state-of-the-art blood test that provides an accurate picture of Alzheimer’s risk through a simple blood sample. By analyzing specific biomarkers linked to Alzheimer’s disease, including p-Tau 217, the test offers over 90% diagnostic accuracy—all without the need for invasive or costly procedures like lumbar punctures or PET imaging.
01
Cost-Effective
At £695, LucentAD Complete is a fraction of the cost of traditional diagnostic methods.
02
High Accuracy
Achieves 90% accuracy in detecting amyloid pathology, giving you and your healthcare provider confidence in the results, aligning with standards set by The Global Initiative.
03
Non-Invasive
Only a blood sample is needed, making it easier, quicker and more comfortable to get tested. Until now highly-invasive Lumbar Puncture tests or PET scans have been required.
04
Fast Results
Receive a detailed risk assessment within 15 working days. The risk assessment can be sent directly to your doctor and you can make an appointment with them to discuss the results and any appropriate next steps.
ABOUT US
Advance Tests collaborates with globally trusted biotech innovators, adopting their breakthrough diagnostic technologies once they meet stringent accreditation and compliance standards in leading healthcare markets.
This enables Advance Tests to rapidly introduce proven tests to the UK, targeting critical patient backlogs and supporting those at high risk due to genetic or symptomatic factors.
How to Book a Test?
WHY CHOOSE ADVANCE TESTS?
Committed to Research
Advance Tests are working with the Centre for Applied and Inclusive Health Research at the University of Wolverhampton to help advance understanding of Alzheimer's Disease.
Accurate
With over 90% accuracy, the only plasma biomarker for diagnosing amyloid pathology which meets the Alzheimer’s Association strict criteria.
Accessible
While authorised in the US, this test is not yet available on the NHS but is being made available by Advance Tests years ahead of the NHS schedule.
Medical Professional?
Get Tested.
Take Control.
Seeking to understand the likelihood of Alzheimer's can feel overwhelming. However, knowing and understanding key bio-markers can empower you to take control of your future, offering clarity, access to early treatment options, and the ability to plan ahead with confidence.
It can also stop the uncertainty of not knowing, and for many allows them to rule out Alzheimer's at this time.
Adopt Lifestyle Changes
Extensive research has shown that lifestyle changes can significantly impact the progression of Alzheimer's. By knowing early, your doctor and caregivers can recommend personalised lifestyle adjustments that can enhance your quality of life and potentially extend it.
Explore Treatment Options
The MHRA has recently approved two promising new drugs, Lecanemab and Donanemab, both of which can delay symptom onset and enhance quality of life. Although not currently available through the NHS, they may be accessed privately. Please note, Advance Tests is not affiliated with these medications or their manufacturers.
Plan with Confidence
Knowing earlier allows you to take important steps in planning for the future. By arranging care preferences, securing legal documents, drafting a will and appointing a power of attorney, you ensure your wishes are respected and loved ones supported. Proactive steps provide peace of mind, empowering you to focus on living well now.
Reassurance in a Clear Result
A test result that rules out Alzheimer's offers reassurance and clarity. By ruling out Alzheimer's, you and your healthcare provider can focus on exploring other potential causes of symptoms, ensuring you receive the right care and treatment. For many, a negative result also provides relief, removing the uncertainty and worry, allowing them to move forward with confidence.
Where to Find Us
Our first testing location is conveniently situated at St Thomas Street, London Bridge Station, directly adjacent to Guy’s Hospital. Additional clinics will soon be available in major cities across the UK to make this test accessible nationwide.
If the London clinic is not suitable for you, please tell us here where you would like our next clinic to be.